Inogen get $22 million from Danish pharmaceutical company Novo Nordisk

“Inogen, Inc., a Santa Barbara-based designer and manufacturer of devices that help people suffering from respiratory illnesses, announced on February 16 that it had secured $22 million from the venture capital arm of the Danish pharmaceutical company Novo Nordisk to apply toward research and development of new devices. According to Inogen, the money will help popularize the Inogen One, a portable, 10-pound respiratory aid the company says could replace the bulkier models currently used by those who have difficulty breathing.”